By inquiry, there are 11 Tinibs currently in NDA status, as shown in the table. Here, it should be noted that Anlotinib hydrochloride, which is from Chia Tai Tianqing, has just been approved by China's Drug Administration for listing (2018.5.9). It is hoped that Anlotinib hydrochloride will become an example of the current Tinibs drugs in NDA, thus leading to more safe and effective Tinibs drugs on the market.